FLR's third-quarter 2024 results reflect lower-than-expected contributions from the Energy Solutions segment.

FLR's third-quarter 2024 results reflect lower-than-expected contributions from the Energy Solutions segment.

SRDX fiscal fourth-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate.

QDEL's third-quarter results reflect growth in non-respiratory revenues along with a lowering of operating expenses year over year. However, the gross...

PCRX reports mixed third-quarter 2024 results, wherein earnings beat estimates but revenues miss. Exparel sales witness year-over-year growth.

ACAD reports encouraging third-quarter results as earnings and revenues beat estimates. Nuplazid and Daybue sales record year-over-year growth.

Trimble's third-quarter 2024 results benefit from strong subscription and services revenues, backed by robust guidance for continued growth.

MAS' third-quarter 2024 results benefit from operational improvements. Yet, challenged market demand ails the top line.

FORM's third-quarter 2024 results benefit from record DRAM probe-card revenues on strong demand. Its weak guidance hurts shares.

FORM's third-quarter 2024 results benefit from record DRAM probe-card revenues on strong demand. Its weak guidance hurts shares.